Hook / Thesis
I was skeptical of Credo Technology a few months ago because the valuation looked stretched and customer concentration was obvious. I was wrong. The company just delivered a quarter that materially shifts the fundamental picture: Q1 revenue of $407 million (about 201% year-over-year growth) and blistering gross margins near 68.5% show Credo is not a niche supplier but a high-margin enabler of the AI data center build-out. The market sold the stock off on short-term technicals and rotation; that pullback is now an opportunity.
My thesis: Credo is a critical connectivity supplier for hyperscale AI data centers, with product-level differentiation that supports durable growth and high incremental margins. At current levels the stock offers asymmetric upside for disciplined, risk-managed buyers. This is a rating upgrade and an actionable trade: buy on a measured entry, size for volatility, and use a tight stop to respect the concentrated-customer and valuation risks.
What the company does and why the market should care
Credo Technology develops connectivity solutions for data infrastructure - integrated circuits, Active Electrical Cables (AECs), and SerDes chiplets that sit between GPUs and switches inside AI racks. Those components are the plumbing of modern AI clusters: low-latency, high-bandwidth links with minimal power loss. Hyperscalers are building massive AI farms and need reliable, power-efficient interconnects. Credo's AECs are positioned as a cost- and power-efficient alternative to optical, with the company claiming much higher reliability and lower power draw at scale. For investors, that means Credo participates directly in hyperscaler capex cycles and benefits from both unit volume and attractive gross margins.
Recent performance and key numbers
The headline Q1 metric is $407 million in revenue, a 201% year-over-year jump. The quarter delivered gross margins of roughly 68.5% and adjusted EPS beats (quarterly adjusted EPS reported at $1.07). On a trailing basis, reported earnings per share are about $1.84 and the stock trades at a P/E of roughly 55x. Market capitalization sits near $18.8 billion and enterprise value is about $17.54 billion. Price-to-sales on the trailing metric is elevated around 17.6x, and EV/TTM sales is approximately 16.4x. Free cash flow is meaningful at roughly $283.7 million, which supports reinvestment into product ramps and M&A if needed.
Technically, the stock has pulled below shorter-term moving averages: the 10-day and 20-day SMAs are around $110.79 and $112.79, while the 50-day is $124.33. Momentum indicators show some exhaustion - RSI near 40 and a slightly negative MACD histogram - which opened an entry window after the post-earnings rotation.
| Metric | Value |
|---|---|
| Most recent quarter revenue | $407,000,000 |
| Gross margin (recent quarter) | ~68.5% |
| Market cap | $18.8 billion |
| Enterprise value | $17.54 billion |
| TTM EPS | $1.84 |
| P/E (TTM) | ~55x |
| Free cash flow (TTM) | $283.7 million |
| 52-week range | $29.09 - $213.80 |
Valuation framing
Yes, Credo is expensive on headline multiples. P/E near 55x and price-to-sales above 17x assume many years of rapid growth and margin retention. But the other side of that equation is growth and gross margin quality: 201% revenue growth in the most recent quarter and gross margins north of 68% are not typical for a hardware supplier. If Credo can sustain high growth while converting revenue into cash flow (it already produced roughly $283.7 million in free cash flow), then the headline multiples start to look like the premium you pay for a category leader in AI interconnects. Put simply: the valuation is demanding, but the business metrics - exceptional growth, high incremental margins, and strong FCF generation - provide a credible route to justify that premium if execution continues.
Catalysts (what could drive the stock higher)
- Continued hyperscaler ramp and diversification beyond the two largest customers that currently account for a large share of revenue - more customers would reduce perceived concentration risk.
- New product ramps (next-gen AECs, SerDes chiplets) that expand TAM per rack and increase content per system.
- Quarterly results that sustain 50%+ YoY revenue growth guidance for FY2027 and improved operating leverage.
- Positive industry headlines around AI data center buildouts and spend commitments from hyperscalers.
- Further share buybacks or accretive M&A funded by strong free cash flow could improve investor sentiment.
Trade plan (actionable)
Entry: Buy at $101.92.
Stop loss: $92.00.
Target: $160.00.
Trade direction: Long.
Horizon: long term (180 trading days) - I expect product ramps, customer diversification, and FY2027 guidance to play out over multiple quarters, making a 6-month horizon appropriate to capture both operational execution and multiple expansion if the thesis proves correct.
Why this plan? The entry sits near current levels after the post-earnings pullback. Use the $92 stop to respect downside from customer concentration and multiple volatility; it limits the position to a defined loss if sentiment deteriorates. The $160 target reflects a recovery toward mid-cycle optimism that assumes continued double-digit top-line growth and improved visibility into diversified revenue streams. At $160 the market would be pricing growth materially above today's base but still well under the prior 52-week high of $213.80, giving room for upside if execution accelerates.
Risks and counterarguments
- Customer concentration: Two hyperscalers accounted for approximately 80% of recent quarter revenue. If either pulls back on purchases or internalizes the technology, growth and margins would take a hit.
- Valuation sensitivity: At P/E ~55x and price-to-sales >17x the stock is sensitive to any miss in growth guidance. A single quarter of disappointment could rapidly compress multiples.
- Competition and technology risk: Optical interconnects and other chip-to-chip solutions are evolving. If competitors achieve parity in power, cost, or reliability, Credo's premium could erode.
- Execution risk: Rapid manufacturing scale and supply chain execution are non-trivial for high-speed interconnect hardware. Any production hiccups would delay revenue and reduce investor confidence.
- Macro / cyclical risk: Hyperscaler capex can be lumpy and subject to macro sentiment - a broader slowdown in AI infrastructure spend would hit Credo hard.
Counterargument: The biggest pushback is valuation: you can make the case that the stock is still priced for near-perfect execution and that customer concentration leaves no margin for error. If a large customer decelerates, multiples compress quickly and the business could re-rate significantly. That is a legitimate path for underperformance and supports a cautious position sizing.
Why I'm upgrading despite those risks
Two reasons change my mind. First, the revenue and margin profile are not the numbers of a cyclical, low-margin supplier; they look structural and tied to a secular AI infrastructure trend that should persist for years. Second, the company is converting revenue into free cash flow at a meaningful clip ($283.7 million), which gives management options to invest, M&A, or return capital, and reduces the probability of a pure multiple collapse. For traders and investors who accept higher risk, the reward-to-risk here is attractive with a disciplined stop.
What would change my mind
- Clear evidence that the two largest customers pause or reduce spending materially beyond normal lumpy orders.
- Emergence of a competitor that demonstrably matches Credo's performance profile at meaningfully lower cost.
- Quarterly results showing margin erosion or negative free cash flow, which would indicate product or pricing stress.
Conclusion
I was dead wrong to remain negative on Credo when the product ramp and margin durability were this strong. That honesty matters: the data changed, so my view changed. This is a high-conviction upgrade to a buy for traders willing to accept volatility and concentrated-customer risk. Execute the trade with a strict stop at $92, target $160 over the next 180 trading days, and size your position appropriately. If Credo continues to execute and diversifies its customer base, this trade has asymmetric upside. If the risks materialize, the stop preserves capital and lets you reassess on new information.